The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery
1 other identifier
observational
100
1 country
1
Brief Summary
Lung cancer surgery causes significant changes in the small circulation as well as changes in the intrathoracic anatomy. The effects of lung cancer surgery on electrocardiography and the cardiac stress associated with the procedures have not been previously extensively studied. The aim of the present study is to ascertain whether modern mini-invasive lung cancer surgery causes changes in the electrocardiogram, and whether these changes are transitory during short-term follow-up. Furthermore, the study aims to describe whether lung cancer surgery causes significant cardiac stress detectable by intraoperative electrocardiography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2021
CompletedFirst Posted
Study publicly available on registry
October 26, 2021
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
September 10, 2025
September 1, 2025
6.8 years
October 1, 2021
September 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (13)
Postoperative electrocardiographic p-, R-, and T-wave amplitude changes
Amplitude changes in the 12-lead rest electrocardiography in millimeters, analyzed daily postoperatively.
2 weeks
Postoperative QRS-duration
The duration of the QRS-complex in milliseconds in the electrocardiogram, measured daily postoperatively using 12-lead rest electrocardiogram.
2 weeks
Postoperative PQ-delay
Changes in the PQ-delay in milliseconds in the 12-lead rest electrocardiogram measured daily postoperatively.
2 weeks
Postoperative QT-interval
The duration of QT-interval in milliseconds in the 12-lead rest electrocardiogram measured daily postoperatively.
2 weeks
The postoperative incidence of new bundle branch blocks
New complete or partial bundle branch blocks, such as RBBB, in the 12-lead rest electrocardiogram.
2 weeks
Postoperative ST-level changes
ST-level changes in millimeters in the 12-lead rest electrocardiogram
3 days
Postoperative P-wave, QRS-complex, and T-wave axle changes
The occurrence and type of P-wave, QRS-complex, and T-wave axle changes in the postoperative 12-lead rest electrocardiogram
2 weeks
Postoperative heart rate
Postoperative heart rate variability in continuous electrocardiographic monitoring
1 week
Postoperative arrhythmias
Arrhythmia rate as well as their type during the early postoperative period detected by continuous electrocardiogram monitoring
1 week
Perioperative ST-level changes
The occurrence, duration (in minutes) as well as the magnitude (in millimeters) of perioperative ST-elevation or depression in the continuous perioperative electrocardiographic monitoring.
1 day
Perioperative heart rate variability
Heart rate levels perioperatively in the continuous perioperative electrocardiographic monitoring.
1 day
Perioperative arrhythmias
The occurrence and type of perioperative arrhythmias, such as atrial fibrillation or flutter, or ventricular tachycardia in the perioperative electrocardiographic monitoring.
1 day
Perioperative R- and T-wave amplitude changes
The amplitude (in millimeters) of possible R- and T-wave amplitude changes in the perioperative electrocardiographic monitoring.
1 day
Secondary Outcomes (2)
Postoperative air leak
1 week
Need for reoperation
1 week
Eligibility Criteria
Patients undergoing elective, curatively aimed, primary lung cancer surgery using mini-invasive surgical techniques.
You may qualify if:
- Adult patients scheduled for elective lung cancer surgery
- Willing to participate in the study
- Curatively aimed surgery
- Preoperative decision for mini-invasive surgery
You may not qualify if:
- Participation in any other clinical trial
- Previous chronic or paroxysmal atrial fibrillation or atrial flutter
- Cardiac pacemaker
- History of cardiac conduction disturbances including bundle branch blocks
- History of cardiac ablation procedures
- History of previous surgery in the thoracic area including open heart surgery
- Preoperatively anticipated need for concomitant thoracic wall resection
- Preoperatively anticipated need for open surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Heart Hospita, Tampere University Hospital
Tampere, Pirkanmaa, 33580, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jahangir Khan
MD, PhD
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2021
First Posted
October 26, 2021
Study Start
March 1, 2022
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
September 10, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share